查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2085200

生物製藥物流市場：2026-2032年全球市場預測（依產品類型、服務類型、運輸方式、溫度需求及最終用戶分類）

Bio-Pharmaceutical Logistics Market by Product Type, Service Type, Mode Of Transport, Temperature Requirement, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物製藥物流市場規模將達到 2,064.4 億美元，年複合成長率為 12.31%。

主要市場統計數據
基準年 2025 915.6億美元
預計年份：2026年 1025.6億美元
預測年份 2032 2064.4億美元
複合年成長率 (%) 12.31%

生物製藥物流是生命科學公司實現策略成長的關鍵驅動力。這是因為生物製藥、疫苗、細胞和基因療法、臨床試驗材料以及特種藥品都需要檢驗的溫度控制、清晰可見的儲存歷史記錄以及符合監管要求的文件。與傳統貨運不同，生物製藥供應鏈必須確保產品在常溫、冷藏、冷凍和超低溫運輸過程中，其特性、功效、無菌性和病患安全性始終得到保障。

該領域的發展受到可衡量的醫療保健需求、日益嚴格的藥品良好分銷規範 (GDP) 要求以及高附加價值療法的擴展的影響。世界衛生組織 (WHO) 一直強調疫苗品質取決於有效的低溫運輸管理，而美國食品藥物管理局 (FDA) 和歐洲監管機構等也日益提高對序列化、可追溯性、品質系統和資料完整性的要求。因此，醫藥物流供應商在檢驗的低溫運輸包裝、路線合格、即時監控、偏差控制以及建立具有彈性的全球網路等方面展開競爭。

物流業的變革

生物製藥物流格局正從簡單的運輸作業轉向端到端的產品管理。隨著生物製藥、生物相似藥、GLP-1療法、抗癌藥物、疫苗和先進處方藥的成長，對溫控倉儲、專業宅配服務、低溫處理和直接送達患者模式的需求日益成長。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過改善需求預測、路線最佳化、溫度偏差預測、倉庫人員配置規劃、海關文件審核和異常管理，正在生物製藥物流整體產生協同效應。透過將 AI 模型與物聯網感測器、GPS 遙測數據、天氣數據、航班時刻表、海關里程碑、庫存記錄和品質數據相整合，物流團隊可以從被動干預轉變為主動預測風險。

對關鍵區域的洞察

隨著生技藥品生產、臨床試驗、疫苗分發以及特藥取得在中國、印度、日本、韓國、澳洲和東協等市場的擴張，亞太地區正經歷快速成長。該地區多樣化的地理特徵、不斷成長的醫療保健行業投資以及全球參與臨床開發的程度日益提高，使得溫控藥品物流、經驗證的包裝以及進出口合規成為重中之重。北美憑藉其美國豐富的先進療法研發管線、基於《藥品供應鏈安全法案》(DSCSA) 的可追溯性、強大的第三方物流(3PL) 基礎設施以及加拿大長途醫療品管路線上符合 GDP 標準的低溫運輸，仍然是一個高價值的樞紐。

小組的主要見解

隨著製藥公司將其生產和臨床供應鏈多元化擴展至新加坡、馬來西亞、泰國、印尼、越南和菲律賓等國，東協的重要性日益凸顯。這一區域成長的驅動力來自醫療保健支出、貿易協調以及低溫運輸設施的改善。在機場貨運能力、物流園區、自由區基礎設施和國家醫療現代化計畫的支持下，海灣合作理事會（GCC）正逐步成為連接歐洲、亞洲和非洲的溫控配送橋樑。

主要國家的概況

美國憑藉其先進的療法、透過專業藥房進行的藥品分銷、分散式臨床試驗模式以及基於FDA《藥品供應鏈安全法案》（DSCSA）的包裝級可追溯性要求，在專業物流的複雜性方面處於領先地位。加拿大強調在長途運輸和氣候變遷地區提供品質保證的低溫運輸配送，而墨西哥則透過近岸外包、藥品生產和跨境醫療物流不斷提升其重要性。巴西憑藉大規模的醫療保健系統、免疫接種計劃以及生物製藥的日益普及，為拉丁美洲地區的需求提供了支持。

為行業領導者提供的實用建議

產業領導者在擴大運輸能力之前，應優先考慮設計檢驗的低溫運輸網路、對供應商合格、建立品質協議並評估每條運輸路線的風險。投資於即時溫度監控、可重複使用且合格的包裝、自動化品質文件以及符合GDP標準的倉庫管理，能夠透過減少溫度偏差、縮短放行週期、改進偏差管理以及增強審計準備能力，帶來可衡量的價值。

調查方法

本執行摘要基於一套系統的調查方法，該方法結合了二手資料研究、監管審查、市場製圖和專家解讀。資訊來源包括衛生當局的公共指南、GDP和GxP框架、海關和貿易相關文件、物流認證項目、醫療基礎設施指標、藥品供應鏈標準以及關於生產、臨床試驗、免疫接種和醫療服務可及性的公開數據。

結論

生物製藥物流正發展成為一個高度專業化的領域，品質保證、數位化可視性、法規遵循和網路彈性決定著競爭優勢。隨著藥品日益個人化、對溫度敏感、價值更高、時效性更強，物流供應商和製藥企業必須將每一次運輸視為產品生命週期中受監管的延伸環節來管理。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：生物製藥物流市場：依產品類型分類

  • 生物製劑
  • 血液製品
  • 疫苗

第8章：生物製藥物流市場：依服務類型分類

  • 低溫運輸包裝
  • 海關清關程序
  • 貨物運輸
  • 倉儲/配送
  • 附加價值服務
    • 套件服務
    • 標籤服務
    • 品質檢驗

第9章：生物製藥物流市場：依運輸方式分類

  • 航空
  • 鐵路
  • 道路運輸
  • 海上運輸

第10章：生物製藥物流市場：依溫度要求分類

  • 環境的
  • 極低溫度
  • 冰凍
  • 冷藏

第11章：生物製藥物流市場：依最終用戶分類

  • 診所
  • 受託研究機構
  • 醫院
  • 製藥公司
  • 研究機構

第12章：生物製藥物流市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：生物製藥物流市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 生物製藥物流市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agility Public Warehousing Company KSCP
  • Air Canada Cargo Inc.
  • Almac Group Limited
  • AmerisourceBergen Corporation
  • Biocair Limited
  • CH Robinson Worldwide, Inc.
  • Cardinal Health, Inc.
  • CEVA Logistics AG
  • Cryoport Inc.
  • DB Schenker
  • DHL Group
  • DSV Panalpina A/S
  • FedEx Corporation
  • GEODIS SA
  • Kerry Logistics Network Limited
  • Kuehne+Nagel International AG
  • MNX Global Logistics LLC
  • Movianto Group
  • Nippon Express Co., Ltd.
  • PCI Pharma Services Holdings LLC
  • QuickSTAT Global Life Science Logistics Inc.
  • SF Express Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • United Parcel Service, Inc.
  • World Courier Inc.
Product Code: MRR-437D459587C9

The Bio-Pharmaceutical Logistics Market is projected to grow by USD 206.44 billion at a CAGR of 12.31% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 91.56 billion
Estimated Year [2026] USD 102.56 billion
Forecast Year [2032] USD 206.44 billion
CAGR (%) 12.31%

Bio-pharmaceutical logistics has become a strategic growth engine for life sciences organizations as biologics, vaccines, cell and gene therapies, clinical trial materials, and specialty medicines require validated temperature control, chain-of-custody visibility, and regulatory-ready documentation. Unlike conventional freight, bio-pharma supply chains must protect product identity, potency, sterility, and patient safety across controlled ambient, refrigerated, frozen, and ultra-low-temperature lanes.

The sector is being shaped by measurable healthcare demand, stricter good distribution practice requirements, and the expansion of high-value therapies. The WHO has consistently emphasized that vaccine quality depends on effective cold-chain management, while regulators such as the U.S. FDA and European authorities continue to elevate expectations around serialization, traceability, quality systems, and data integrity. As a result, pharmaceutical logistics providers are competing on validated cold chain packaging, lane qualification, real-time monitoring, deviation management, and resilient global network design.

Transformative Shifts in the Logistics Landscape

The bio-pharmaceutical logistics landscape is shifting from shipment execution to end-to-end product stewardship. Growth in biologics, biosimilars, GLP-1 therapies, oncology medicines, vaccines, and advanced therapy medicinal products is increasing demand for temperature-controlled warehousing, specialty courier services, cryogenic handling, and direct-to-patient distribution models.

At the same time, supply chain leaders are redesigning networks for resilience after pandemic-era disruption, geopolitical risk, extreme weather, and capacity volatility exposed weaknesses in long, single-source distribution routes. Compliance frameworks such as EU Good Distribution Practice, U.S. Drug Supply Chain Security Act requirements, IATA pharmaceutical handling standards, and national import controls are driving investment in traceability, validated packaging, qualified carriers, quality agreements, and digital control towers.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding gains across bio-pharmaceutical logistics by improving demand forecasting, route optimization, temperature excursion prediction, warehouse labor planning, customs document review, and exception management. When AI models are connected to IoT sensors, GPS telemetry, weather feeds, airline schedules, customs milestones, inventory records, and quality data, logistics teams can move from reactive intervention to predictive risk mitigation.

The strongest use cases are practical and auditable: AI-assisted lane qualification, automated deviation triage, predictive maintenance for cold rooms and refrigerated vehicles, dynamic packaging selection, inventory positioning, and document intelligence for customs and quality release. However, adoption must remain aligned with GxP validation, cybersecurity controls, data integrity principles, explainability, and human oversight because AI recommendations can affect regulated product quality and patient outcomes.

Key Regional Insights

Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, Australia, and ASEAN markets scale biologics manufacturing, clinical trials, vaccine distribution, and specialty medicine access. The region's diverse geography, rising healthcare investment, and increasing participation in global clinical development are making temperature-controlled pharmaceutical logistics, validated packaging, and import-export compliance central priorities. North America remains a high-value hub due to the United States' advanced therapy pipeline, DSCSA-driven traceability, strong third-party logistics infrastructure, and Canada's GDP-aligned cold-chain standards across long-distance healthcare distribution routes.

Europe benefits from harmonized EU GDP expectations, dense cross-border healthcare distribution, established serialization requirements, and mature pharmaceutical manufacturing clusters in Germany, France, Italy, Spain, and the United Kingdom. Latin America is strengthening cold-chain capability around Brazil and Mexico, although infrastructure variability, security considerations, and customs complexity make lane validation critical. The Middle East is becoming a strategic transit and healthcare logistics hub through GCC investments in airports, free zones, and life sciences infrastructure, while Africa's opportunity is tied to vaccine access, regional cold storage, public health programs, and last-mile reliability improvements supported by international immunization and healthcare supply initiatives.

Key Group Insights

ASEAN is gaining importance as pharmaceutical companies diversify manufacturing and clinical supply chains across Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, with regional growth supported by healthcare spending, trade connectivity, and improving cold-chain assets. The GCC is positioning itself as a temperature-controlled distribution bridge between Europe, Asia, and Africa, supported by airport cargo capacity, logistics parks, free-zone infrastructure, and national healthcare modernization programs.

The European Union provides one of the most structured regulatory environments for bio-pharmaceutical logistics through GDP guidance, Falsified Medicines Directive serialization, pharmacovigilance expectations, and cross-border market access. BRICS economies are central to long-term demand because they combine large patient populations with expanding domestic pharmaceutical production, public health distribution needs, and growing biologics capabilities. G7 markets remain the innovation and reimbursement anchors for high-value biologics, vaccines, and advanced therapies, while NATO-aligned logistics capabilities can influence resilience planning, emergency preparedness, secure medical supply routes, and contingency logistics for critical healthcare products.

Key Country Insights

The United States leads in specialty logistics complexity due to advanced therapies, specialty pharmacy distribution, decentralized clinical trial models, and FDA DSCSA package-level traceability requirements. Canada emphasizes quality-assured cold-chain distribution across long distances and variable climates, while Mexico is gaining relevance through nearshoring, pharmaceutical manufacturing, and cross-border healthcare logistics. Brazil anchors Latin American demand with a large healthcare system, immunization programs, and growing biologics adoption.

In Europe, the United Kingdom remains a clinical research and specialty distribution hub, Germany combines pharmaceutical manufacturing strength with advanced logistics infrastructure, France maintains strong public health and biopharma capacity, Russia requires careful risk, sanctions, and compliance management, and Italy and Spain support mature pharmaceutical manufacturing and hospital distribution networks. In Asia-Pacific, China and India are critical manufacturing and demand centers with expanding biologics and vaccine capabilities, Japan prioritizes high-quality regulated distribution and precise cold-chain execution, Australia requires robust long-distance cold-chain planning across dispersed population centers, and South Korea is becoming a major biopharma manufacturing and clinical supply market supported by advanced healthcare infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize validated cold-chain network design, supplier qualification, quality agreements, and lane-level risk assessment before expanding capacity. Investments in real-time temperature monitoring, reusable and qualified packaging, automated quality documentation, and GDP-compliant warehousing deliver measurable value by reducing excursions, shortening release cycles, improving deviation control, and strengthening audit readiness.

Companies should also establish AI governance, integrate control tower data with quality management systems, and develop contingency routes for customs delays, carrier disruptions, temperature excursions, product recalls, and extreme weather. Strategic partnerships with certified carriers, specialty couriers, airlines, packaging providers, clinical supply specialists, and regional healthcare distributors are essential for scaling global reach without compromising product integrity, regulatory compliance, or patient safety.

Research Methodology

This executive summary is built using a structured research methodology that combines secondary research, regulatory review, market mapping, and expert interpretation. Sources include public guidance from health authorities, GDP and GxP frameworks, customs and trade references, logistics certification programs, healthcare infrastructure indicators, pharmaceutical supply chain standards, and public data on manufacturing, clinical trials, immunization, and healthcare access.

Insights are validated through triangulation across regulatory evidence, operational benchmarks, regional logistics conditions, and demand signals from pharmaceutical manufacturing, clinical development, biologics adoption, specialty medicine distribution, and public health programs. The methodology emphasizes data-backed conclusions, avoids unsupported market claims, and focuses on factors that materially affect bio-pharmaceutical logistics performance, compliance, resilience, and patient-centric delivery.

Conclusion

Bio-pharmaceutical logistics is evolving into a highly specialized discipline where quality assurance, digital visibility, regulatory compliance, and network resilience determine competitive advantage. As medicines become more personalized, temperature-sensitive, high-value, and time-critical, logistics providers and pharmaceutical manufacturers must manage every shipment as a regulated extension of the product lifecycle.

Organizations that combine validated infrastructure, AI-enabled risk management, global compliance expertise, qualified partner ecosystems, and regional execution strength will be best positioned to serve the next generation of biologics, vaccines, clinical trial materials, and advanced therapies. The sector's direction is clear: patient safety, product integrity, and data-driven logistics excellence will define leadership.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Bio-Pharmaceutical Logistics Market, by Product Type

  • 7.1. Biologics
  • 7.2. Blood Products
  • 7.3. Vaccines

8. Bio-Pharmaceutical Logistics Market, by Service Type

  • 8.1. Cold Chain Packaging
  • 8.2. Customs Clearance
  • 8.3. Freight Forwarding
  • 8.4. Storage And Distribution
  • 8.5. Value Added Services
    • 8.5.1. Kitting Services
    • 8.5.2. Labeling Services
    • 8.5.3. Quality Inspection

9. Bio-Pharmaceutical Logistics Market, by Mode Of Transport

  • 9.1. Air
  • 9.2. Rail
  • 9.3. Road
  • 9.4. Sea

10. Bio-Pharmaceutical Logistics Market, by Temperature Requirement

  • 10.1. Ambient
  • 10.2. Cryogenic
  • 10.3. Frozen
  • 10.4. Refrigerated

11. Bio-Pharmaceutical Logistics Market, by End User

  • 11.1. Clinics
  • 11.2. Contract Research Organizations
  • 11.3. Hospitals
  • 11.4. Pharmaceutical Companies
  • 11.5. Research Institutes

12. Bio-Pharmaceutical Logistics Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Bio-Pharmaceutical Logistics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bio-Pharmaceutical Logistics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agility Public Warehousing Company K.S.C.P.
  • 16.2. Air Canada Cargo Inc.
  • 16.3. Almac Group Limited
  • 16.4. AmerisourceBergen Corporation
  • 16.5. Biocair Limited
  • 16.6. C.H. Robinson Worldwide, Inc.
  • 16.7. Cardinal Health, Inc.
  • 16.8. CEVA Logistics AG
  • 16.9. Cryoport Inc.
  • 16.10. DB Schenker
  • 16.11. DHL Group
  • 16.12. DSV Panalpina A/S
  • 16.13. FedEx Corporation
  • 16.14. GEODIS S.A.
  • 16.15. Kerry Logistics Network Limited
  • 16.16. Kuehne + Nagel International AG
  • 16.17. MNX Global Logistics LLC
  • 16.18. Movianto Group
  • 16.19. Nippon Express Co., Ltd.
  • 16.20. PCI Pharma Services Holdings LLC
  • 16.21. QuickSTAT Global Life Science Logistics Inc.
  • 16.22. SF Express Co., Ltd.
  • 16.23. Thermo Fisher Scientific Inc.
  • 16.24. United Parcel Service, Inc.
  • 16.25. World Courier Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COLD CHAIN PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COLD CHAIN PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COLD CHAIN PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CUSTOMS CLEARANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CUSTOMS CLEARANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CUSTOMS CLEARANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FREIGHT FORWARDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FREIGHT FORWARDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FREIGHT FORWARDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STORAGE AND DISTRIBUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STORAGE AND DISTRIBUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STORAGE AND DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VALUE ADDED SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VALUE ADDED SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VALUE ADDED SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL KITTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL KITTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL KITTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LABELING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LABELING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LABELING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL QUALITY INSPECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL QUALITY INSPECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL QUALITY INSPECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RAIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RAIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RAIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ROAD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ROAD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ROAD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SEA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SEA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AMBIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AMBIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AMBIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CRYOGENIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CRYOGENIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CRYOGENIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FROZEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FROZEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FROZEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL REFRIGERATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL REFRIGERATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL REFRIGERATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 134. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 135. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 136. GCC BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 155. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 156. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 157. G7 BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 162. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 163. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 164. NATO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 177. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 178. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 179. CANADA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 184. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 185. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 186. MEXICO BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 191. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 192. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 193. BRAZIL BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED KINGDOM BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 205. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 206. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 207. GERMANY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 213. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 214. FRANCE BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 220. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 221. RUSSIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 226. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 227. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 228. ITALY BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 233. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 234. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 235. SPAIN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 247. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 248. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 249. INDIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 254. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 255. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 256. JAPAN BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 261. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 262. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 263. AUSTRALIA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 269. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 270. SOUTH KOREA BIO-PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)